Armstrong Advisory Group’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Armstrong Advisory Group's TEVA Position: Q3 2026 in Review
Armstrong Advisory Group held its Teva Pharmaceutical Industries (TEVA) position steady in Q3 2026 at 93 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #836.
Armstrong Advisory Group first reported a position in TEVA in Q3 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Armstrong Advisory Group held 93 shares of Teva Pharmaceutical Industries worth $3.68K as of Q3 2026.
- Armstrong Advisory Group left its Teva Pharmaceutical Industries share count unchanged in Q3 2026.
- Teva Pharmaceutical Industries made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #836 holding.
- Armstrong Advisory Group first reported a position in Teva Pharmaceutical Industries in Q3 2025 and has held it in 5 quarters since.
- 598 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.